BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8988728)

  • 1. Increasing incidence of and declining mortality from breast carcinoma. Trends in Malmö, Sweden, 1961-1992.
    Garne JP; Aspegren K; Balldin G; Ranstam J
    Cancer; 1997 Jan; 79(1):69-74. PubMed ID: 8988728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.
    Zackrisson S; Andersson I; Janzon L; Manjer J; Garne JP
    BMJ; 2006 Mar; 332(7543):689-92. PubMed ID: 16517548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gothenburg Breast Screening Trial.
    Bjurstam N; Björneld L; Warwick J; Sala E; Duffy SW; Nyström L; Walker N; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Salander H; Säve-Söderbergh J; Wahlin T
    Cancer; 2003 May; 97(10):2387-96. PubMed ID: 12733136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and breast cancer survival in relation to the introduction of mammographic screening.
    Olsson A; Garne JP; Tengrup I; Zackrisson S; Manjer J
    Eur J Surg Oncol; 2009 Dec; 35(12):1261-7. PubMed ID: 19481409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994.
    Matson S; Andersson I; Berglund G; Janzon L; Manjer J
    Cancer Detect Prev; 2001; 25(2):132-7. PubMed ID: 11341348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
    Suhrke P; Mæhlen J; Zahl PH
    Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening.
    Ernst MF; Voogd AC; Coebergh JW; Roukema JA
    Cancer; 2004 Apr; 100(7):1337-44. PubMed ID: 15042665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.
    Ikeda DM; Andersson I; Wattsgård C; Janzon L; Linell F
    AJR Am J Roentgenol; 1992 Aug; 159(2):287-94. PubMed ID: 1632342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography screening and breast cancer mortality in Sweden.
    Autier P; Koechlin A; Smans M; Vatten L; Boniol M
    J Natl Cancer Inst; 2012 Jul; 104(14):1080-93. PubMed ID: 22811439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mammographic service screening on stage at presentation of breast cancers in Sweden.
    Swedish Organised Service Screening Evaluation Group
    Cancer; 2007 Jun; 109(11):2205-12. PubMed ID: 17471486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Service screening mammography reduces breast cancer mortality among elderly women in Turku.
    Parvinen I; Helenius H; Pylkkänen L; Anttila A; Immonen-Räihä P; Kauhava L; Räsänen O; Klemi PJ
    J Med Screen; 2006; 13(1):34-40. PubMed ID: 16569304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.